EstechPharma Co. Ltd (041910) - Total Assets
Based on the latest financial reports, EstechPharma Co. Ltd (041910) holds total assets worth ₩195.93 Billion KRW (≈ $132.78 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 041910 net asset value for net asset value and shareholders' equity analysis.
EstechPharma Co. Ltd - Total Assets Trend (2013–2025)
This chart illustrates how EstechPharma Co. Ltd's total assets have evolved over time, based on quarterly financial data.
EstechPharma Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
EstechPharma Co. Ltd's total assets of ₩195.93 Billion consist of 38.5% current assets and 61.5% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 13.7% |
| Accounts Receivable | ₩14.48 Billion | 7.4% |
| Inventory | ₩16.07 Billion | 8.2% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩3.22 Billion | 1.7% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how EstechPharma Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of EstechPharma Co. Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: EstechPharma Co. Ltd's current assets represent 38.5% of total assets in 2025, an increase from 0.0% in 2013.
- Cash Position: Cash and equivalents constituted 13.7% of total assets in 2025, up from 11.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, unchanged from 1.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 8.2% of total assets.
EstechPharma Co. Ltd Competitors by Total Assets
Key competitors of EstechPharma Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Komipharm International Co. Ltd
KQ:041960
|
Korea | ₩133.65 Billion |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩529.96 Billion |
|
ST Pharm Co.Ltd
KQ:237690
|
Korea | ₩782.57 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩154.14 Billion |
|
Caregen Co.Ltd
KQ:214370
|
Korea | ₩233.98 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Mezzion Pharma Co.Ltd
KQ:140410
|
Korea | ₩87.88 Billion |
|
Huons Global Co. Ltd
KQ:084110
|
Korea | ₩1.47 Trillion |
EstechPharma Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.61 | 16.58 | 8.14 |
| Quick Ratio | 2.06 | 12.99 | 6.22 |
| Cash Ratio | 0.00 | 9.90 | 0.00 |
| Working Capital | ₩46.59 Billion | ₩73.50 Billion | ₩63.77 Billion |
EstechPharma Co. Ltd - Advanced Valuation Insights
This section examines the relationship between EstechPharma Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.68 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 45.7% |
| Total Assets | ₩195.93 Billion |
| Market Capitalization | $59.21 Million USD |
Valuation Analysis
Below Book Valuation: The market values EstechPharma Co. Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: EstechPharma Co. Ltd's assets grew by 45.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for EstechPharma Co. Ltd (2013–2025)
The table below shows the annual total assets of EstechPharma Co. Ltd from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩195.93 Billion ≈ $132.78 Million |
+45.73% |
| 2024-12-31 | ₩134.45 Billion ≈ $91.12 Million |
+10.30% |
| 2023-12-31 | ₩121.90 Billion ≈ $82.61 Million |
-1.95% |
| 2022-12-31 | ₩124.32 Billion ≈ $84.25 Million |
-7.47% |
| 2021-12-31 | ₩134.36 Billion ≈ $91.05 Million |
+9.10% |
| 2020-12-31 | ₩123.15 Billion ≈ $83.46 Million |
+5.77% |
| 2019-12-31 | ₩116.43 Billion ≈ $78.90 Million |
+18.38% |
| 2018-12-31 | ₩98.34 Billion ≈ $66.65 Million |
+3.57% |
| 2017-12-31 | ₩94.95 Billion ≈ $64.35 Million |
-2.58% |
| 2016-12-31 | ₩97.47 Billion ≈ $66.06 Million |
+6.69% |
| 2015-12-31 | ₩91.36 Billion ≈ $61.92 Million |
-20.24% |
| 2014-12-31 | ₩114.56 Billion ≈ $77.63 Million |
+9.76% |
| 2013-12-31 | ₩104.37 Billion ≈ $70.73 Million |
-- |
About EstechPharma Co. Ltd
EstechPharma Co., Ltd. manufactures and sells pharmaceuticals products. It also offers raw materials, such as RBM and PLK. The company was formerly known as Estech Chemical and changed its name to EstechPharma Co., Ltd. in January 2001. EstechPharma Co., Ltd. was founded in 1996 and is headquartered in Hwaseong-si, South Korea.